secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOGEN INC. (BIIB)
CIK:        0000875045
Form:       8-K
Filed at:   2024-10-30T23:59:59+00:00
Accession:  0001193125-24-247628
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Biogen CFO Michael McDonnell to retire Feb 2025; Robin Kramer named successor
-----------------------------------------------------------------------------

- Michael McDonnell to retire as CFO effective February 28, 2025, after serving since August 2020.
- Robin Kramer, current Chief Accounting Officer, appointed CFO effective upon McDonnell's retirement.
- Kramer's base salary $750,000; target bonus 80% of base; 2025 target LTI grant $3.75 million.
- Kramer joined Biogen in 2018, served as CAO since 2020, also leads Treasury, procurement, and global business services.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/875045/000119312524247628/0001193125-24-247628-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/875045/000119312524247628/d890797d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-247628

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer